Cargando…
What We Have Learned about Autism Spectrum Disorder from Valproic Acid
Two recent epidemiological investigations in children exposed to valproic acid (VPA) treatment in utero have reported a significant risk associated with neurodevelopmental disorders and autism spectrum disorder (ASD) in particular. Parallel to this work, there is a growing body of animal research li...
Autores principales: | Chomiak, Taylor, Turner, Nathanael, Hu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871912/ https://www.ncbi.nlm.nih.gov/pubmed/24381784 http://dx.doi.org/10.1155/2013/712758 |
Ejemplares similares
-
Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here
por: Anagnostou, Evdokia, et al.
Publicado: (2011) -
Heterogeneity within Autism Spectrum Disorders: What have We Learned from Neuroimaging Studies?
por: Lenroot, Rhoshel K., et al.
Publicado: (2013) -
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2022) -
The State of the Dopaminergic and Glutamatergic Systems in the Valproic Acid Mouse Model of Autism Spectrum Disorder
por: Maisterrena, Alexandre, et al.
Publicado: (2022) -
Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)